Carregant...
Venetoclax: evidence to date and clinical potential
The emergence of targeted therapy for patients with hematological diseases has permanently altered the therapeutic landscape. Immunochemotherapy regimes are now more and more being replaced by targeted therapies due to superior efficacy and better safety profiles. However, evolution and selection of...
Guardat en:
| Publicat a: | Drugs Context |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioExcel Publishing Ltd
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6788387/ https://ncbi.nlm.nih.gov/pubmed/31645879 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.212574 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|